Bausch & Lomb CORP (BLCO) — SEC Filings

Overview

Bausch & Lomb CORP (BLCO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K/A filed on Dec 22, 2025: Bausch + Lomb Corporation filed an amendment (8-K/A) on December 22, 2025, to a previous report concerning events on December 17, 2025. The filing relates to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements

Sentiment Summary

Across 25 filings, the sentiment breakdown is: 1 bearish, 23 neutral, 1 mixed. The dominant filing sentiment for Bausch & Lomb CORP is neutral.

Filing Type Overview

Bausch & Lomb CORP (BLCO) has filed 1 8-K/A, 14 8-K, 6 10-Q, 2 DEF 14A, 2 10-K with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (25)

• Bausch + Lomb Files 8-K/A Amendment on Officer/Director Changes — 8-K/A · Dec 22, 2025 Risk: medium
  Bausch + Lomb Corporation filed an amendment (8-K/A) on December 22, 2025, to a previous report concerning events on December 17, 2025. The filing relates to th
• Bausch + Lomb Files 8-K on Officer/Director Changes — 8-K · Dec 17, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K on December 17, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of
• Bausch + Lomb Files Routine 8-K — 8-K · Dec 12, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K report on December 12, 2025. The filing indicates no specific material events or financial updates were disclosed beyond
• Bausch + Lomb Files 8-K Report — 8-K · Nov 13, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K report on November 13, 2025, to disclose information under Regulation FD and to file financial statements and exhibits. T
• Bausch & Lomb Navigates Recall, Tariffs Amidst BHC Separation — 10-Q · Oct 29, 2025 Risk: high
  Bausch & Lomb Corp (BLCO) reported a mixed financial performance for the three and nine months ended September 30, 2025. While specific revenue and net income f
• Bausch + Lomb Corp: Agreement Termination & Officer Changes — 8-K · Aug 18, 2025 Risk: medium
  Bausch + Lomb Corporation announced on August 14, 2025, the termination of a material definitive agreement. The company also reported changes in its board of di
• Bausch & Lomb Sees Modest Q2 Revenue Growth Amidst Competitive Pressures — 10-Q · Jul 30, 2025 Risk: medium
  Bausch & Lomb Corp (BLCO) reported product revenue of $1.01 billion for the second quarter of 2025, a slight increase from $990 million in the second quarter of
• Bausch + Lomb Announces Executive and Director Changes — 8-K · Jul 23, 2025 Risk: medium
  Bausch + Lomb Corporation announced on July 21, 2025, changes in its executive team and board of directors. The filing details the departure of certain officers
• Bausch & Lomb Corp Files 8-K: Material Agreement & Financials — 8-K · Jun 27, 2025 Risk: medium
  On June 26, 2025, Bausch & Lomb Corporation entered into a material definitive agreement, creating a direct financial obligation. The company also reported othe
• Bausch + Lomb Files 8-K — 8-K · Jun 18, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K on June 18, 2025, to report other events and financial statements. The filing details the company's principal executive o
• Bausch + Lomb Files 8-K — 8-K · Jun 10, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K on June 10, 2025, reporting other events and financial statements. The filing provides no specific financial figures or m
• Bausch + Lomb Files 8-K on Security Holder Votes — 8-K · May 21, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K on May 21, 2025, to report on the submission of matters to a vote of security holders. The filing does not contain specif
• Bausch + Lomb Files 8-K Report — 8-K · May 21, 2025 Risk: low
  Bausch + Lomb Corporation filed an 8-K on May 21, 2025, reporting an event that occurred on May 19, 2025. The filing details their principal executive offices l
• Bausch & Lomb Files Q1 2025 10-Q — 10-Q · Apr 30, 2025 Risk: low
  Bausch & Lomb Corp filed a 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of
• Bausch + Lomb Files Definitive Proxy Statement — DEF 14A · Apr 10, 2025 Risk: low
  Bausch + Lomb Corporation filed a Definitive Proxy Statement (DEF 14A) on April 10, 2025, for the fiscal year ending December 31, 2025. The filing concerns the
• Bausch & Lomb Corp. Files 2024 10-K — 10-K · Feb 19, 2025 Risk: medium
  Bausch & Lomb Corp. filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The filing provides comprehensive financial
• Bausch & Lomb Corp. Enters Material Definitive Agreement — 8-K · Nov 1, 2024 Risk: medium
  On November 1, 2024, Bausch & Lomb Corp. entered into a material definitive agreement related to a direct financial obligation. The filing does not specify the
• Bausch & Lomb Corp Files Q3 2024 10-Q — 10-Q · Oct 30, 2024 Risk: medium
  Bausch & Lomb Corp filed a 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Spec
• Bausch & Lomb Q2 2024: $1.9B in Sales, $10.38B Assets — 10-Q · Aug 1, 2024 Risk: low
  Bausch & Lomb Corp reported its Q2 2024 results, with net sales for the six months ended June 30, 2024, reaching $1.905 billion. The company's balance sheet as
• Bausch + Lomb Files 8-K on Financials — 8-K · Jul 31, 2024 Risk: low
  Bausch + Lomb Corporation filed an 8-K on July 31, 2024, to report on its results of operations and financial condition, and to file financial statements and ex
• Bausch + Lomb Corp Reports Director Changes and Compensation Updates — 8-K · May 29, 2024 Risk: medium
  Bausch + Lomb Corporation announced on May 29, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure
• Bausch & Lomb Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024 Risk:
  Bausch & Lomb Corp (BLCO) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Bausch & Lomb Corp filed a 10-Q report for the period ending March 31, 20
• Bausch & Lomb Corp Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 29, 2024 Risk: low
  Bausch & Lomb Corp (BLCO) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Bausch & Lomb Corp filed a DEF 14A form on April 29, 2024. The filin
• Bausch + Lomb Announces General Counsel Transition — 8-K · Feb 28, 2024 Risk: low
  Bausch + Lomb Corporation filed an 8-K on February 27, 2024, reporting the departure of Christina Ackermann as Executive Vice President, General Counsel, and Co
• Bausch & Lomb Corp Files 2023 Annual Report (10-K) — 10-K · Feb 21, 2024 Risk: medium
  Bausch & Lomb Corp (BLCO) filed a Annual Report (10-K) with the SEC on February 21, 2024. Bausch & Lomb Corp filed its 10-K report for the fiscal year ending De

Risk Profile

Risk Assessment: Of BLCO's 24 recent filings, 1 were flagged as high-risk, 10 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• Brenton L. Saunders
• Joseph C. Papa
• Christina Ackermann
• Kelly Webber

Industry Context

The ophthalmology market is characterized by innovation in surgical devices, pharmaceuticals, and contact lenses. Bausch & Lomb operates in a competitive landscape with established players and emerging technologies. Key trends include an aging global population driving demand for vision correction and treatment of age-related eye conditions, as well as advancements in minimally invasive surgical techniques.

Top Tags

8-k (4) · corporate-governance (3) · sec-filing (3) · corporate-filing (3) · Ophthalmic Goods (3) · 10-Q (3) · financials (3) · ophthalmic-goods (3) · Bausch & Lomb (3) · officer-changes (2)

Executive Compensation

From the most recent DEF 14A filing (Apr 29, 2024):

• Brenton L. Saunders — Member
• Joseph C. Papa — Member

Key Numbers

• Common Shares Outstanding: 354,189,784 — As of October 22, 2025, indicating the current equity structure.
• Q2 2025 Product Revenue: $1.01B — Increased from $990M in Q2 2024, showing modest growth.
• Six-Month Product Revenue (2025): $2.01B — Up from $1.97B in the prior year period, indicating consistent top-line expansion.
• Q2 2025 Comprehensive Income: $10M — Decreased from $15M in Q2 2024, signaling potential margin pressure.
• Q2 Product Revenue Growth: 2% — Calculated as ($1.01B - $990M) / $990M, indicating modest year-over-year growth.
• Q2 Comprehensive Income Decline: 33% — Calculated as ($15M - $10M) / $15M, highlighting a significant drop in profitability.
• Fiscal Year End: 2025 — Indicates the end of the reporting period for financial statements.
• Filing Date: 2025-02-19 — Date the 10-K was submitted to the SEC.
• Public Document Count: 97 — Indicates the volume of documents associated with this filing.
• Net Sales (YTD): $1.905B — Represents revenue generated in the first half of 2024.
• Total Assets: $10.38B — Indicates the total resources owned by the company as of June 30, 2024.
• Total Liabilities: $6.27B — Shows the total obligations of the company as of June 30, 2024.
• Period of Report: 2024-05-29 — The period the filing pertains to
• SEC File Number: 001-41380 — SEC filing identifier

Related Companies

BHC

Frequently Asked Questions